Leap Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $10 | $0 |
Gross Profit | 5 | |||
EBITDA | -16,636 | -15,917 | -12,534 | -17,855 |
EBIT | -12,831 | -17,356 | ||
Net Income | -16,643 | -15,435 | -15,431 | -18,176 |
Net Change In Cash | 0 | 0 | 10 | 0 |
Free Cash Flow | -14,486 | -14,480 | -15,512 | -15,600 |
Cash | 18,130 | 32,713 | 47,249 | 62,823 |
Basic Shares | 41,444 | 41,268 | 41,252 | 41,209 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $375 | $1,500 |
Gross Profit | -5 | -427 | -415 | 1,500 |
EBITDA | -66,965 | -80,987 | -53,980 | -40,014 |
EBIT | -66,970 | -81,414 | -54,395 | -40,570 |
Net Income | -67,555 | -81,414 | -54,596 | -40,587 |
Net Change In Cash | 0 | 0 | 375 | 1,500 |
Cost of Revenue | 62,878 | |||
Free Cash Flow | -60,299 | -43,753 | -49,044 | -35,157 |
Cash | 47,249 | 70,643 | 65,500 | 114,916 |
Basic Shares | 37,550 | 20,445 | 11,323 | 8,582 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.40 |
2025-03-31 | -$0.37 |
2024-12-31 | -$0.37 |
2024-09-30 | -$0.44 |
